SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D9B1DDCE8DB5BEF0AB450C54200EB9545BB50F873D08342135BA2F83311610AA5296B8A7DF25B4E50B7F05F1F8897CE8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D9B1DDCE8DB5BEF0AB450C54200EB9545BB50F873D08342135BA2F83311610AA5296B8A7DF25B4E50B7F05F1F8897CE8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D9B1DDCE8DB5BEF0AB450C54200EB9545BB50F873D08342135BA2F83311610AA5296B8A7DF25B4E50B7F05F1F8897CE8
http://www.w3.org/2000/01/rdf-schema#comment
"These findings indicate that miR-200c exerts tumor-suppressive effects for NSCLC through the suppression of USP25 expression and suggests a new therapeutic application of miR-200c in the treatment of NSCLC."
xsd:string
http://purl.uniprot.org/uniprot/#_F163C71760FA3B5D8C2EC73AF0679F8CEA095B4AF62726AC44E6DF32397AEFA92E51FE17FAEAAAF70F910838E3359D20
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D9B1DDCE8DB5BEF0AB450C54200EB9545BB50F873D08342135BA2F83311610AA5296B8A7DF25B4E50B7F05F1F8897CE8
http://purl.uniprot.org/uniprot/Q96B65
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D9B1DDCE8DB5BEF0AB450C54200EB9545BB50F873D08342135BA2F83311610AA5296B8A7DF25B4E50B7F05F1F8897CE8
http://purl.uniprot.org/uniprot/#_Q96B65-mappedCitation-24997798
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D9B1DDCE8DB5BEF0AB450C54200EB9545BB50F873D08342135BA2F83311610AA5296B8A7DF25B4E50B7F05F1F8897CE8